Academies and Workshops are independent programs from NEI Congress. Each requires a separate registration and fee.
Attendees can earn up to 21.25 CME/CE credits by attending all the sessions offered during Congress. Sessions will be held in Mountain Time (MT). The agenda is subject to change.
Child and Adolescent Psychiatry Academy
Broadmoor Hall
4.5 credits
Lunch Industry Symposium†: Addressing Unresolved Symptoms of Major Depressive Disorder (MDD): The Importance of Norepinephrine, Serotonin, and Dopamine Modulation
Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck
— International Center
Michael Thase, MD
Adolescents and Substance Use Disorders: A Combustible Combination
Timothy E. Wilens, MD
Assessment and Treatment of Pediatric Impulsive Aggression: A Transdiagnostic Issue
Adelaide S. Robb, MD
Identification and Treatment of the Self-Harming and Suicidal Adolescent
Nicole Ballinger, DO, MPH, FAPA
Pediatric OCD: From Compulsion to Clomipramine
Jeffrey R. Strawn, MD
Forensics Psychiatry Academy
Colorado Hall
4.5 credits
Lunch Industry Symposium†: Addressing Unresolved Symptoms of Major Depressive Disorder (MDD): The Importance of Norepinephrine, Serotonin, and Dopamine Modulation
Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck
— International Center
Michael Thase, MD
Mental Health Diversion for Individuals With Schizophrenia
Katherine Warburton, DO
The Most Secure and Intensive Treatment Setting: Cases, Lessons Learned, Questions Ahead
Carolina A. Klein, MD
Managing the Unique Challenges of Correctional Psychiatry
Charles L. Scott, MD
The Antisocial Personality Spectrum: Diagnosis and Treatment
James L. Knoll, IV, MD
Industry Scientific Poster Reception †
Sponsored by Sunovion and Otsuka Medical Affairs
— Estate House
Pre-Conference Workshop: Precision Psychiatry
Broadmoor Hall
3.25 credits
Breakfast Scientific Poster Session†
Sponsored by Supernus Pharmaceuticals, Inc.
— International Center
Vladimir Maletic, MD, MS
Blue Genes: Using Pharmacogenetics to Guide Prescribing
Jeffrey R. Strawn, MD
Take Two Tablets and Call Me in the Morning: Prescription Digital Therapeutics
Andrew J. Cutler, MD
Pragmatic Precision Psychiatry: Utilizing Pharmacokinetics and Pharmacodynamics to Optimize Antipsychotic Treatment
Jonathan M. Meyer, MD
Precision Mental Health: Using Biotypes to Personalize Treatment Selection for Mood Disorders
Manpreet K. Singh, MD, MS
NEI Congress
Broadmoor Hall
21.25 credits
Lunch Industry Symposium†: Are You Talking With Your Adult Patients Living With Bipolar I Disorder About Maintenance Treatment with A Long-Acting Injectable (LAI)?
Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck
— Colorado Hall
Todd Broder, MD and Laura Melaro, DNP, APRN, FNP-BC, PMHNP-BC
Lunch Industry Symposium †: A Case of Parkinson’s Disease Psychosis: Managing Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
Sponsored by Acadia Pharmaceuticals, Inc.
— International Center
Gustavo Alva, MD, DFAPA and Susan Scanland, MSN, CRNP, GNP-BC CDP
In the Red: Diagnosis and Treatment of Bipolar Mania
Roger S. McIntyre, MD, FRCPC
Adding On: Utilizing Adjunctive Medications in the Treatment of Major Depressive Disorder
Thomas L. Schwartz, MD
Exhibit Hall Networking Break
Under the Covers: Update on the Diagnosis and Treatment of Insomnia
Andrew J. Cutler, MD and Jade Wu, PhD, DBSM
Thank You, Next: Switching Antipsychotic Medications
Jonathan M. Meyer, MD
Dinner Industry Symposium†: A Novel Nonstimulant Treatment Option for ADHD
Sponsored by Supernus Pharmaceuticals, Inc.
— International Center
Theresa R. Cerulli, MD and Gregory Mattingly, MD
Breakfast Industry Symposium†: TAAR1: Science Behind a Potential New TAARget for Schizophrenia
— International Center
Craig Chepke, MD, FAPA, Vladimir Maletic, MD, MS and Gregory Mattingly, MD
Tipping the Scales: Overcoming Antipsychotic Side Effects to Improve Treatment Adherence
Roger S. McIntyre, MD, FRCPC
All the Livelong Day: Optimizing Adult ADHD Treatment
Andrew J. Cutler, MD
Exhibit Hall Networking Break
Morning Industry Symposium†: The Biology of Depression: Shifting the Focus From Receptor Pharmacology to Neurocircuitry
— Bartolin Hall
Sponsored by Otsuka Pharmaceutical Development and Commercialization Inc
Madhukar H. Trivedi, MD
Talk to Me: Patient Communication in Schizophrenia
Leslie Citrome, MD, MPH and Amber Hoberg, NP
Lunch Industry Symposium†: The Management of Bipolar I Disorder
Sponsored by AbbVie
— International Center
Rakesh Jain, MD, MPH
Lunch Industry Symposium†: Clinical Considerations Regarding the Differential Diagnosis and Management of TD
Sponsored by Teva
— Colorado Hall
Richard Jackson, MD
Keep It Steady: Maintenance Treatment for Bipolar Disorders
Leslie Citrome, MD, MPH
Don't Fall Asleep: Screening, Diagnosis, and Management of Narcolepsy and Idiopathic Hypersomnia
Thomas L. Schwartz, MD
Exhibit Hall Networking Break / Scientific Poster Session
— Bartolin Hall
Afternoon Industry Symposium†: Forging A New Path: Targeting Muscarinic Receptor Circuits in Schizophrenia
Sponsored by Karuna Therapeutics
— Bartolin Hall
Julie A. Carbray, PhD, PMHNP-BC, PM-HCNS-BC, APRN and Rakesh Jain, MD, MPH
On the Blue End: Diagnosis and Treatment of Bipolar Depression
Manpreet K. Singh, MD, MS and Andrew J. Cutler, MD
New Kids on the Block: Novel Receptor Science in the Treatment of Major Depressive Disorder
Andrew J. Cutler, MD
Dinner Industry Symposium†: Making a Difference for Patients With Tardive Dyskinesia (TD) Proactively Recognizing and Treating an Overlooked Disorder
Sponsored by Teva Pharmaceuticals
— International Center
Richard Jackson, MD
Breakfast Industry Symposium†: Clinical Evidence Supporting the Use of a Once-Daily Atypical Antipsychotic for Bipolar Depression: Bipolar I or II
Sponsored by Intra-Cellular Therapies, Inc.
— International Center
Gregory W. Mattingly, MD
To the Moon and Back: Pediatric ADHD
Napoleon B. Higgins, Jr., MD
Case-Based Differential Diagnosis of Movement Disorders
Laxman B. Bahroo, DO
Exhibit Hall Networking Break
Morning Industry Symposium†: Advancing the Understanding of the Biological Mechanisms of Depression
Sponsored by Sage Therapeutics, Inc. and Biogen Inc.
Bartolin Hall
Rakesh Jain, MD
Fast As You Can: Rapid-Acting Treatments for Depression
Kari L. Franson, PharmD, PhD, BCPP and Andrew J. Cutler, MD
Exhibit Hall Networking Break
Lunch Industry Symposium†: The Efficacy and Safety Profile of an Adjunctive Therapy for Adult Patients With Major Depressive Disorder (MDD)
Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck
— International Center
Vladimir Maletic, MD, MS
Lunch Industry Symposium†: Rethink Treatment for Adults with Schizophrenia or Bipolar I Disorder
Sponsored by Alkermes
— Colorado Hall
Craig Chepke, MD
Target Acquired? New Receptor Science in the Treatment of Schizophrenia
Stephen M. Stahl, MD, PhD, DSc (Hon.)
Reasons to Hope: Evidence-Based Actions for Suicide Prevention
Christine Moutier, MD, and Stephen Stahl, MD, PhD, DSc (Hon.)
Exhibit Hall Networking Break
Afternoon Industry Symposium†: Agitation Associated with Alzheimer's Dementia (AAD): Clinical Presentation & Pathophysiology, Current Treatment & Unmet Need
Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck
— Bartolin Hall
David Sultzer, MD
Moving in the Right Direction: An Update on the Treatment of Tardive Dyskinesia
Laxman B. Bahroo, DO and Andrew J. Cutler, MD
Early Use of LAI Antipsychotics for Patient Adherence, Relapse Prevention, and Brain Preservation
Leslie Citrome, MD, MPH and Andrew J. Cutler, MD
Dinner Industry Symposium†: Coordination of Care Between Referring Psychiatrists and Treatment Center Provider
Sponsored by Janssen Pharmaceuticals
— International Center
Lisa Harding, MD and Vladimir Maletic, MD, MS
Breakfast Industry Symposium†: The Impact of Tardive Dyskinesia: The Data and a Patient Story
Sponsored by Neurocrine Biosciences, INC.
— International Center
Craig T.M. Chepke, MD
No Woman, No Cry: Advancements in the Diagnosis and Treatment of Postpartum Depression
Mary C. Kimmel, MD
When All Else Fails: Managing Treatment-Resistant Depression
William M. Sauvé, MD
A New Dawn? Recent Developments in Early Diagnosis and Treatment of Alzheimer's Disease
Danielle Goldfarb, MD
Neuropsychiatric Symptoms in Alzheimer's Disease: Focus on Agitation
Stephen Stahl, MD, PhD, DSc (Hon.)
A Calming Presence: Managing Agitation in Bipolar Disorder and Schizophrenia
Leslie Citrome, MD, MPH
Lunch Industry Symposium†: Beyond the Monoamine Hypothesis: A Glutamatergic Approach to Treating Major Depressive Disorder
Sponsored by Axsome Therapeutics, Inc.
— International Center
†The content of all non-CME/CE events (Industry Symposia, Disease State Sessions, and Poster Sessions) and the views expressed therein are those of the presenting entity and not of NEI. They are not part of the scientific program and do not provide CME/CE credit. By attending a non-CME/CE event, the attendee opts in to receive follow-up information from the commercial sponsor.